A merger with Mylan would “transform the global generics space” says Teva, which has entered a $40bn bid as an alternative to the recently proposed Mylan-Perrigo merger.
An anti-fungal drug shows potential to treat a range of cancers, according to research from the Repurposing Drugs in Oncology (ReDO) project.
Almost 600 staff at Allergan’s headquarters in Irvine, California, will be laid off in the Botox maker’s latest round of job cuts.
Pfizer and Regeneron are in Cuba this week, scouting the country for business opportunities.
GEA said it expects to achieve a moderate organic growth in revenue and an operating EBITDA of between €580 and €620m in the current fiscal year 2015, but its growth is overshadowed by 1,450 job cuts.
Johnson & Johnson will scale up manufacturing of a three-day wearable patch pump used to deliver insulin, in preparation for a post 2015 launch.